HONG KONG, Dec. 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest umbilical cord blood banking operator in China, today announced the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong.
At the Annual General Meeting, shareholders
- Elected Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve on the Board of Directors until the 2014 Annual General Meeting of the Company or until their respective successors are duly appointed and qualified; and
- Ratified the appointment of KPMG as the independent auditor of the Company for the financial year ending March 31, 2012, and authorized the directors to fix the remuneration of the auditors.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
In New York: Ashley M. Ammon: 1-646-277-1227
In Beijing: Wen Lei Zheng: +86-10-6583-7510
Related biology technology :1
|SOURCE China Cord Blood Corporation|
Copyright©2010 PR Newswire.
All rights reserved
. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise2
. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results3
. China Biologic to Host Earnings Conference Call on November 8, 2011 at 8:00 a.m. EST (NY)4
. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China5
. China Biologic Named to Asias "200 Best Under a Billion" by Forbes Asia6
. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report7
. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee8
. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 20119
. Industrial Biotechnology China News 1109 - Annual Subscription10
. ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China11
. China Cord Blood Corporation Files Its Annual Report on Form 20-F